Study to Evaluate the Long‑Term Safety, Tolerability and Efficacy of Subcutaneous Marstacimab in Subjects With Severe Hemophilia

A Multicenter, Open‑Label Study to Evaluate the Long‑Term Safety, Tolerability and Efficacy of Subcutaneous PF‑06741086 in Subjects With Severe Hemophilia. A Multicenter, Open‑Label Study to Evaluate the
Long‑Term Safety, Tolerability and Efficacy of Subcutaneous PF‑06741086 in Subjects With Severe
Hemophilia

Category & Conditions: Rare Diseases

Medicine: marstacimab (PF-06741086)

ClinicalTrials.gov Identifier (NCT): NCT03363321

Protocol ID: B7841003

Print Download

Open Plain Language Summary Result: Click here